HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kjaergard, H. K. Articles by Fairbrother, J. E. Search for Related Content PubMed PubMed Citation Articles by Kjaergard, H. K. Articles by Fairbrother, J. E.

European Journal of Cardio-Thoracic Surgery, Vol 10, 727-733, Copyright © 1996 by European Association for Cardio-thoracic Surgery

ARTICLES

Controlled clinical studies of fibrin sealant in cardiothoracic surgery- -a review

HK Kjaergard and JE Fairbrother
Department of Cardiothoracic Surgery, Gentofte University Hospital, Hellerup, Denmark.

OBJECTIVE: More than 2300 clinical papers have been published on the surgical applications of fibrin sealant (FS), with the largest number in the speciality of cardiothoracic surgery. The purpose of this review of the literature was to find and evaluate controlled studies published in the field of cardiothoracic surgery, to clarify the indications and emphasize the benefits of FS available to the practising surgeon. METHODS: A database of the surgical publications of FS was created. Up to the end of 1995, at least 24 controlled clinical studies had been published; these may be divided into 20 studies with a positive outcome and 4 studies where the results were not different from the controls. In none of the studies was the clinical result worse after the use of FS. RESULTS: In most of the cardiac studies, FS was successfully used at bleeding sites in reoperations and in congenital heart surgery. Postoperative bleeding may also be reduced by the anterior mediastinal spray application of FS or by preparing woven Dacron prostheses with the sealant. In addition, Fs has been found to improve results after type A aortic disections and, by adding an antibiotic to the sealant, the postoperative infection rate for active endocarditis of the aortic root can be reduced. In pulmonary surgery FS can be used to reduce pulmonary air leakage, however the results of some studies diverge due to different clinical test conditions and the inclusion of only a small number of patients in the "negative" studies. In none of the controlled studies of esophageal surgery could FS prevent leakage from esophageal anastomoses. CONCLUSIONS: Fibrin sealant is safe when it is applied properly, but there is a learning curve for surgeons who start using it. An autologous sealant or a sealant containing human instead of bovine thrombin is preferred, since repeated use of bovine thrombin may induce coagulopthies. The number of controlled clinical studies of FS is currently increasing, with the majority of the papers revealing a beneficial effect of FS when it is used as a hemostatic or sealing agent in cardiothoracic surgery.

This article has been cited by other articles:

				D. Fink, J. J. Klein, H. Kang, and M. A. Ergin Application of biological glue in repair of intracardiac structural defects Ann. Thorac. Surg., February 1, 2004; 77(2): 506 - 511. [Abstract] [Full Text] [PDF]

				G. Lang, A. Csekeo, G. Stamatis, L. Lampl, L. Hagman, G. M. Marta, M. R. Mueller, and W. Klepetko Efficacy and safety of topical application of human fibrinogen/thrombin-coated collagen patch (TachoComb) for treatment of air leakage after standard lobectomy Eur. J. Cardiothorac. Surg., February 1, 2004; 25(2): 160 - 166. [Abstract] [Full Text] [PDF]

				M. Codispoti and P.S. Mankad Significant merits of a fibrin sealant in the presence of coagulopathy following paediatric cardiac surgery: randomised controlled trial Eur. J. Cardiothorac. Surg., August 1, 2002; 22(2): 200 - 205. [Abstract] [Full Text] [PDF]

				P. D. Mintz, L. Mayers, N. Avery, H. L. Flanagan, S. G. Burks, and W. D. Spotnitz Fibrin Sealant: Clinical Use and the Development of the University of Virginia Tissue Adhesive Center Ann. Clin. Lab. Sci., January 1, 2001; 31(1): 108 - 118. [Abstract] [Full Text] [PDF]

				H. K. Kjaergard and H. R. Trumbull Bleeding from the sternal marrow can be stopped using vivostat patient-derived fibrin sealant Ann. Thorac. Surg., April 1, 2000; 69(4): 1173 - 1175. [Abstract] [Full Text] [PDF]

				H. K. Kjaergard, J. H. Pedersen, M. Krasnik, U. S. Weis-Fogh, H. Fleron, and H. E. Griffin Prevention of Air Leakage by Spraying Vivostat Fibrin Sealant After Lung Resection in Pigs Chest, April 1, 2000; 117(4): 1124 - 1127. [Abstract] [Full Text] [PDF]

				H. K. Kjaergard and H. R. Trumbull Vivostat system autologous fibrin sealant: preliminary study in elective coronary bypass grafting Ann. Thorac. Surg., August 1, 1998; 66(2): 482 - 486. [Abstract] [Full Text] [PDF]